Adma Biologics reported $20K in Ordinary Share Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Adamis Pharmaceuticals ADMP:US USD 15.05K 0
Adma Biologics ADMA:US USD 20K 0
Agile Therapeutics AGRX:US USD 4K 3K
Alnylam Pharmaceuticals ALNY:US USD 1.23M 20K
Minerva Neurosciences NERV:US USD 1000 0
Novavax NVAX:US USD 792K 4K
Omeros OMER:US USD 627K 0
Takeda 4502:JP JPY 1.68T 53M